Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-010637
Filing Date
2026-02-23
Accepted
2026-02-23 16:18:52
Documents
1
Period of Report
2026-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1771881526.html 4  
1 FORM 4 wk-form4_1771881526.xml 4 4063
  Complete submission text file 0001628280-26-010637.txt   5658
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2001 MARKET STREET SUITE 3915, UNIT 15 PHILADELPHIA PA 19103
Business Address
Chagin Karen Deborah (Reporting) CIK: 0002070710 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40654 | Film No.: 26665449